Novel anti-epileptic drug demonstrates efficacy
European Pharmaceutical Review
OCTOBER 9, 2023
A new approach to potassium-channel openers for epilepsy Critically, XEN1101 combines the effectiveness of potassium-channel openers with the safety of more traditional drugs, stated study lead author and neurologist Dr Jacqueline French. It ran between January 2019 and September 2021.
Let's personalize your content